Specialty medical injectable drug program, requirements and drug policy updates: Aduhelm®
New specialty medical injectable guidelines and requirements announced.
- All states
- Operations
- All Business Sizes
Please review the following table to determine changes to our specialty medical injectable drug programs.
Updates to drug program requirements and drug policies for UnitedHealthcare commercial business effective June 1, 2022
| Drug Name | Treatment Uses | Summary of Changes |
|---|---|---|
| Aduhelm® (aducanumab-avwa) | Used to treat Alzheimer’s disease | Review at Launch program where applicable through May 31, 2022 Reference commercial policy or coverage summary for further details Add prior authorization requirement effective June 1, 2022 |
For questions, please contact your broker or UnitedHealthcare representative.
More updates for your business
New releases, updates and notifications for a broad spectrum of UnitedHealthcare products and services.
Important, required notices for products, plans, forms and more.
Need-to-know operational announcements for you and your employees.